# Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery

> **NCT05334485** · PHASE2,PHASE3 · RECRUITING · sponsor: **Stefan Holubar MD MS FACS, FASCRS** · enrollment: 50 (estimated)

## Conditions studied

- Postoperative Ileus

## Interventions

- **DRUG:** Pyridostigmine Bromide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05334485
- **Lead sponsor:** Stefan Holubar MD MS FACS, FASCRS
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-03
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05334485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05334485, "Pyridostigmine Efficacy and Safety for Treatment of Ileus After Colorectal Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05334485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*